Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fengxian Fu"'
Publikováno v:
Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Objective Estrogen (E2) is the main contributor to the progression of endometrial cancer (EC). The long noncoding RNA HOX antisense intergenic RNA (HOTAIR) is emerging as a new regulator in several cancer types. This study aimed to investigate the ro
Externí odkaz:
https://doaj.org/article/be2b84ee9d36466bb081b1cd62192ee7
Autor:
Xiaoli Xiao, Ruiqing Ma, Lianyao Shi, Cong Wang, Jie Chen, Yiyan Lu, Yufeng Wang, Xichao Zhai, Fengxian Fu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Malignant mixed Müllerian tumor (MMMT) of the fallopian tube is rare and has a poor prognosis. For the patient with fallopian tube MMMT, complete resection of the tumor invading the viscera and the peritoneum is a prerequisite for long-term survival
Externí odkaz:
https://doaj.org/article/e839eca4eead44ffbd866c9651efe8db
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
ObjectiveTo determine prognosis for young female patients with peritoneal pseudomyxoma (PMP) of appendiceal origin and unilateral or bilateral ovaries preserved during cytoreductive surgery (CRS).MethodsClinical data of female patients treated with C
Externí odkaz:
https://doaj.org/article/202a916c486947f295ea4cf13dfe5385
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo describe the clinicopathological characteristics of mucinous ovarian cancer (MOC)-derived pseudomyxoma peritonei (PMP) and identify prognostic factors for survival.MethodsMedical records from patients with MOC-derived PMP who attended the
Externí odkaz:
https://doaj.org/article/58a7879c470f42819cfc70e411f7f960
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo describe the clinicopathological characteristics of mucinous ovarian cancer (MOC)-derived pseudomyxoma peritonei (PMP) and identify prognostic factors for survival.MethodsMedical records from patients with MOC-derived PMP who attended the